EuroPCR 2024: Late-Breaking Science Video Collection
Published: 20 May 2024
-
Views:
1043
-
Likes:
7
-
Views:
1043
-
Likes:
7
-
4m 13sPart 3 | Session 1 5 Trials That Will Change My Practice With Dr Mirvat Alasnag -
6m 27sPart 3 | Session 2 4 Trials That Will Change My Practice with Dr Bernardo Cortese
-
4m 31sPart 1 | Session 1 Self-Expandable Vs Balloon-Expandable Valves & General Vs Local Anesthesia in TAVI: SOLVE-TAVI Hans-Josef Feistritzer
-
3m 44sPart 1 | Session 2 Influence of Pathophysiological Patterns of CAD on PCI Carlos Collet
-
5m 19sPart 1 | Session 3 Ancillary SMART Trial Analyses Roxana Mehran
-
3m 59sPart 1 | Session 4 Impact of Diabetes Severity After Abluminus DES+ Stent: ABILITY Roxana Mehran
-
4m 6sPart 1 | Session 5 TAVR Vs SAVR in Younger Low-Risk Patients with Severe Aortic Valve Stenosis: NOTION-2 Ole De Backer
-
26m 48sPart 1 | Session 6 1M DAPT Followed by 5M Ticagrelor Monotherapy in ACS with DCB: CAGEFREE II Ling Tao
-
26m 3sPart 2 | Session 1 View from the Thoraxcenter: What's Hot at EuroPCR 24? Joost Daemen, Nicolas M Van Mieghem
Overview
Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research.
Hear commentary on the practice-changing trials of EuroPCR 2024 from selected faculty in our Highlights Reviews.
More from this programme
Part 1
Expert Interviews
Part 2
View from the Thoraxcenter
Part 3
Highlights Reviews
About the episode
Explore EuroPCR 24 Top Trials with Insights from the Thoraxcenter!
Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam, for an engaging and critical analysis of the latest trials unveiled at EuroPCR.
In the first segment of this comprehensive EuroPCR review, interventional experts examine the most significant trials, providing valuable insights into their impact on current practices and future research directions.
00:44 - CAREER
03:09 - Angiography-based Radial Wall Strain in Predicting Non-Culprit Vessel Failure
05:30 - DOCTORS-LM
06:18 - TCW
08:55 - SOLVE-TAVI
10:49 - NOTION-2
13:42 - LANDMARK
15:52 - CALIPSO
Recorded on-site at EuroPCR 24, Paris.
Faculty Biographies
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Comments